ALB and diabetic kidney disease: A liraglutide (0.2–0.6 mg/kg/day) treatment for 8 weeks reduced the renal pathologic findings and urinary albumin in early-phase DKD in spontaneously diabetic Torii fatty rats by preventing glomerular endothelial abnormality and preservation of autophagy.